Page 80 - வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immune response to FDA-approved vaccines is strong and potentially long-lasting The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease, but concerns remain over how long immunity induced by the new vaccine technology will last. Now, a study from researchers at Washington University School of Medicine in St. Louis, published June 28 in the journal Nature, has found evidence that the immune response to such vaccines is both strong and potentially long-lasting.

South africaAli ellebedyJane ohalloranWilliam middletonSharlene teefeyJackson turnerRachel prestiEmily hendersonSchool of medicineWashington universityDrug administrationWashington university school of medicineWashington university schoolStudy senior authorAssociate professorMolecular microbiology